$AGN Recent Headlines U.K. stocks advance, but Shire

New Post Public Reply Private Reply Replies (0) Message Board

May 2, 2014 at 10:13 AM

$AGN Recent Headlines

U.K. stocks advance, but Shire loses grip of gains 12:29 p.m. April 29, 2014 - Carla Mozee
Allergan looks for white knight to counter Valeant's hostile bid: reports 11:10 a.m. April 29, 2014 - blogs.marketwatch.com
Allergan looks to Sanofi, J&J for takeover: report 9:48 a.m. April 29, 2014 - Karen Friar
Allergan preparing to approach Shire: report 4:23 p.m. April 28, 2014 - MarketWatch.com
AstraZeneca jumps, leading U.K. stocks higher 12:52 p.m. April 28, 2014 - Carla Mozee
Stock futures point to rise as drug stocks rally 9:29 a.m. April 28, 2014 - Sara Sjolin
Allergan cut to hold by Stifel on takeover risks 7:57 a.m. April 28, 2014 - Ben Eisen
Allergan cut to hold from buy at Stifel Research 7:18 a.m. April 28, 2014 - Barbara Kollmeyer
Pfizer steps up $100 billion bid for AstraZeneca 3:53 a.m. April 28, 2014 - MarketWatch.com
$100 billion M&A week is actually good for bondholders: Barclays 2:24 p.m. April 25, 2014 - blogs.marketwatch.com
In focus: Challenging the all-time highs 9:45 p.m. April 23, 2014 - Lawrence G. McMillan
How to find off the radar stocks 12:07 p.m. April 23, 2014 - blogs.marketwatch.com
Ackman says he's in it for long haul on proposed Valeant-Allergan deal 11:59 a.m. April 23, 2014 - blogs.marketwatch.com
Ackman: Didn't violate insider-trading rules over Allergan 7:58 a.m. April 23, 2014 - Silvia Ascarelli
Ackman: Allergan poison pill lets board explore options 7:42 a.m. April 23, 2014 - Silvia Ascarelli
Game day for Facebook and Apple, volume 'signalling the nasty' 6:50 a.m. April 23, 2014 - blogs.marketwatch.com
Allergan adopts poison pill in face of Valeant bid 3:48 a.m. April 23, 2014 - Liz Hoffman
U.S. stocks gain; S&P 500 extends streak to six 5:14 p.m. April 22, 2014 - Anora Mahmudova
Newscast: Stocks notch another win 4:32 p.m. April 22, 2014 - MarketWatch
S&P 500, Nasdaq extend win streak to 6 sessions: Stock market live blog recap 3:56 p.m. April 22, 2014 - blogs.marketwatch.com

Health Care Stocks Still Healthy Despite Higher Hedging Costs 6:30 a.m. Today - TheStreet.com
Pershing Square L.P. Hedge Fund Gains 7.3% in April 9:13 p.m. May 1, 2014 - The Wall Street Journal Interactive Edition
What's With All The Healthcare And Pharmaceutical Mergers? 5:25 p.m. May 1, 2014 - TheStreet.com
Allergan Inc (AGN): Today's Featured Health Care Winner 5:00 p.m. May 1, 2014 - TheStreet.com
Glaxo Misses on Q1 Earnings, Shares Down - Analyst Blog 2:14 p.m. May 1, 2014 - Zacks.com
Shire's Appeal Doesn't Rest on Takeover Attention 1:10 p.m. May 1, 2014 - The Wall Street Journal Interactive Edition
Shire Raises Earnings Guidance 11:24 a.m. May 1, 2014 - The Wall Street Journal Interactive Edition
Allergan's Options For Fending Off Valeant's Hostile Takeover 7:23 a.m. May 1, 2014 - Seeking Alpha
Novartis' Zykadia Gets FDA Approval - Analyst Blog 6:10 p.m. April 30, 2014 - Zacks.com
Ironwood Up as Loss Narrows, Linzess Shines - Analyst Blog 4:45 p.m. April 30, 2014 - Zacks.com
Will Mylan (MYL) Miss Q1 Earnings? - Analyst Blog 4:26 p.m. April 30, 2014 - Zacks.com
Financial Engineers Hard at Work at Apple, Pfizer 7:40 a.m. April 30, 2014 - Barrons.com
In Drug Mergers, There's One Sure Bet: The Layoffs 7:12 p.m. April 29, 2014 - The Wall Street Journal Interactive Edition
Benzinga's M&A Chatter for Tuesday April 29, 2014 7:07 p.m. April 29, 2014 - benzinga.com
Can Hospira (HSP) Keep the Earnings Streak Alive? - Analyst Blog 5:10 p.m. April 29, 2014 - Zacks.com
Stocks Finish Higher on Solid Earnings 4:14 p.m. April 29, 2014 - TheStreet.com
AstraZeneca Soars as Pfizer Confirms Buyout Talks - Analyst Blog 2:38 p.m. April 29, 2014 - Zacks.com
Icahn And Ackman Kiss And Make Up 12:39 p.m. April 29, 2014 - benzinga.com
Bristol, Merck, Sanofi Report Soft Q1 Sales 11:15 a.m. April 29, 2014 - Investors Business Daily
Allergan Reportedly Seeks Alternate Suitor 9:37 a.m. April 29, 2014 - FOXBusiness

Merger & Acquisition Updates, Quarterly Earnings Releases, and Clinical Trial Results - Analyst Notes on Allergan, Amgen, Furiex, Teva and Alexion 9:00 a.m. May 1, 2014 - PR Newswire - PRF
The World Market for Orphan Drugs 6:59 p.m. April 29, 2014 - PR Newswire - PRF
Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Valeant And Pershing Square Investor Meeting Webcast Replay And Presentations Now Available 3:15 p.m. April 24, 2014 - PR Newswire - PRF
Stock Price Updates, Acquisition Proposals, Upcoming Events, Senior Level Appointments, and Pending Acquisition - Analyst Notes on AstraZeneca, Valeant, WellPoint, Illumina and Forest 8:00 a.m. April 24, 2014 - PR Newswire - PRF
Fitch Places Allergan's Ratings on Negative Watch 3:32 p.m. April 23, 2014 - BusinessWire - BZX
PharmaPoint: Migraine - US Drug Forecast and Market Analysis to 2023 12:30 p.m. April 23, 2014 - PR Newswire - PRF
Critical Alerts For Allergan, SunEdison, Valeant Pharmaceuticals, Shire PLC, and Paychex Released By InvestorsObserver 9:31 a.m. April 23, 2014 - PR Newswire - PRF
Allergan Adopts One-Year Stockholder Rights Plan 8:25 p.m. April 22, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT:Brower Piven Announces the Investigation of Allergan Inc. over the Proposed Takeover of the Company 11:17 a.m. April 22, 2014 - BusinessWire - BZX
Allergan Confirms Receipt of Unsolicited Proposal from Valeant 11:00 a.m. April 22, 2014 - BusinessWire - BZX
ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Proposal 10:12 a.m. April 22, 2014 - BusinessWire - BZX
Allergan Notes Public Filings by Valeant and Pershing Square 10:45 p.m. April 21, 2014 - BusinessWire - BZX
Dr. Rian A. Maercks Announces Appointment to Elite ASCENT National Advisory Panel in Plastic Surgery, Comprised of Top 25 Leaders in Innovative Plastic Surgery in the U.S. 8:45 a.m. April 17, 2014 - PR Newswire - PRF
TauTona Group Sells Aline HA(R) to Allergan 8:30 a.m. April 17, 2014 - Marketwire
Global Laparoscopic Devices Industry 4:19 p.m. April 16, 2014 - PR Newswire - PRF
Top-of-Mind Companies in Facial Injectable and Laser/Energy Device Markets Are Similar in Europe and Asia 10:00 a.m. April 15, 2014 - PR Newswire - PRF
Active Equities under the Scanner -- Research on Allergan, Visa, Starbucks, and Home Depot 8:00 a.m. April 14, 2014 - PR Newswire - PRF
Financial Results Schedules, Approvals, Appointments, Product Launches, and Stock Movements - Analyst Notes on Allergan, Accuray, Cerus, Galena Biopharma, and ZELTIQ Aesthetic 8:00 a.m. April 9, 2014 - PR Newswire - PRF
Sientra Appoints Charlie Huiner as Chief Strategy and Corporate Development Officer 2:00 p.m. April 8, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UST Grabs Italdesign: Driving Future Mobility with AI

UST's Strategic Move Into Automotive's Future Wake up and smell the coffee, because UST is shaking up the automotive scene. They've just pulled off a major play by grabbing a majority stake in Italdesign. If that doesn't scream the next leap forward for the auto world, I don't know what does. UST isn't just buying a company; it's marrying Italdesign's legendary design...

Nuix Leverages AI for Transformative Legal Review

Nuix Unveils AI Innovations in Legal Review Diving headfirst into the evolving world of legal technology, Nuix has just rolled out some serious upgrades to its eDiscovery toolkit. By plucking AI right out of the data science ethers, they're not just dabbling in futuristic tech—they're planting generative AI at the heart of legal review on their SaaS platform, Nuix...

Navimow Powers TOP 14 with Tech: A Winning Play

A Technological Leap for French Rugby Innovation and precision in partnerships—those words don't usually pop up together when chatting about a rugby league. But here we are, discussing the TOP 14, the elite French rugby championship, pairing up with Segway Navimow. This brand, under the umbrella of Ninebot Limited (689009.SH), is stepping into the world of sports for...

Rznomics Unveils Breakthrough in Circular RNA Production

Decoding the RNA Revolution Ever heard of circular RNA (circRNA)? This ain't your typical strand of genetic code. Unlike their straight-laced, linear counterparts, these RNAs form a loop you can't just break. Picture them as the Kevlar vests of the RNA world—tough, resilient, and packing the promise of next-gen treatments in their covalent loops. Here we’ve got...

XiamenAir Takes Off with Fujian-London Link

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Ping An Climbs Sustainability Ladder, Scores A+ Rating

Sustainability Triumph for Ping An: A+ Upgrade Ping An Insurance (Group) Company of China, Ltd. is having quite the moment, snagging an A+ in the latest 2026 Sustainability Rating from Hang Seng Indexes Company. This ain't just a one-time pat on the back—it's the third year of consecutive improvement. Looks like Ping An's focus on ESG efforts is finally getting the...

BYD's Chip Mastery Amid China's Auto Supply Tensions

Chips, the New Battleground in Automotive Innovation Here we are, folks, knee-deep in a tech-driven car revolution where semiconductors aren't just the icing on the cake—they're the cake itself. As vehicles morph into veritable computers on wheels, reliance on chips is hitting a fever pitch. FYI, it's not just about making cars go; we're talking power management,...

CelluPro Earns Global Recognition with EXCiPACT Certification

Breaking New Ground with EXCiPACT Certification Here's a tale unfolding in the high-stakes world of biotechnology—CelluPro, a standout in cell culture media, just snagged the EXCiPACT™ certification. This isn't just some fancy plaque for the wall. It's a stamp of approval that screams reliability in the global biomanufacturing supply scene. Why This Certification...

Mermaid Folklore Meets Revolution in New Short Film

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...